Humira adalimumab: Phase II; approved for rheumatoid arthritis (RA) in U.S. and under review for RA in EU

ABT began a North American Phase II trial in an undisclosed number of patients. The compound was developed with Cambridge Antibody Technology Group plc (LSE:CAT;CATG). ...